News from the Front in War on Cancer--Mission Not Accomplished

Scientific American

Janet Rowley noticed something odd about the glowing chromosomes revealed by her microscope. It was the early 1970s, the first years of the so-called "war on cancer," and she was using a new staining technique to examine cells from patients with chronic myelogenous leukemia (CML), a cancer of the blood that was almost always fatal. The technique highlighted bands within the chromosomes, and she could see an extra piece on the end of chromosome 9. That fragment was nearly the same size as a "missing" chunk of chromosome 22 that other researchers had detected a decade earlier. To Rowley, it looked as if the tips of these two chromosomes had swapped places, or translocated. During the next few years she found two other cases of chromosomal translocation in different forms of leukemia. The finds forever changed the way scientists thought about cancer.

Shuffled chromosomes in leukemia established that broken, scrambled and messed-up genes cause cancer. The genetic code details when cells should grow, divide and eventually die. Cancer is a disease of misinformation—cells ignore the rules, growing despite multiple molecular signals telling them to stop and invading other tissues because they no longer respond to biological messages to stay put or even destroy themselves. In the past four decades scientists have identified thousands of genetic mistakes that either cause cancer or boost the risk of developing it. The effects of these typos are sometimes dramatic—the gene variants BRCA1 and BRCA2 can boost women's lifetime risk of developing breast cancer from 12 percent to 60 percent. Some errors are found only in cancer cells themselves; other changes can be passed from generation to generation. The latter are the mistakes that may be passed down and boost the risk of developing cancer—this is the inherited genetic risk, or the reason that people with a familial history of a disease may want to get tested earlier or more often.

As researchers uncover more genetic mistakes and delve deeper into the human genome, it may be possible to pin down the exact probabilities conferred by inherited genetic risk. If clinicians could scan a healthy person's genes for variations that explain their probability of developing cancer, perhaps they could prevent or catch the disease before it became a problem: Spit into this vial and the doctor will tell you what will ail you in 20 years.

Despite the plummeting cost of DNA sequencing technology, much of the information is a jumble of alphabet soup. Science can figure out what gene variants and markers a person has, but they can't tell exactly what it means for his or her health. It will take researchers years to untangle the genetics of cancer. Even large steps, heralded as a major advances, answer few questions and pose many more.

This spring, a massive international collaboration doubled the number of known genetic regions associated with the risk of breast, prostate or ovarian cancers. The genetic markers are signpost that researchers can follow to better understand the biology of these cancers. Only a few of the 74 newly identified markers are shared by more than one type of cancer, underscoring cancer's complexity. Yet exactly how the findings can inform public health recommendations remains to be discovered. Each marker is associated with small modifications of risk, but the effects add up. The findings could lead to more accurate cancer screening and hint at ways cancers could be caught before the disease becomes aggressive. Only further study, however, will show where to draw the lines between risk percentages that tell patients "not to worry" or "get tested now."

Reams of data

The impressive number of hits in the new work stems from the size of the research effort: 160 institutions around the world analyzed a pool of more than 200,000 individuals' genetic sequences. The international project is called the Collaborative Oncological Gene-environment Study (COGS). To find the dozens of new cancer risk regions, researchers combed the pooled genetic information for variations called single-nucleotide polymorphisms (SNPs). A SNP is change in a single letter of the DNA code, likely introduced as a "typo" during gene replication. If such a change happens within a gene, it can affect the structure of proteins. If it falls within a stretch of DNA that regulates genes, it can affect the amount of protein a cell produces.

The COGS researchers put 211,000 SNPs of interest, which were previously identified in other studies, on a custom-made DNA array that looks a bit like a computer chip. Then they used the chip to scan the pooled genetic information to look for differences between people who had cancer and those who did not. If a particular SNP popped up more often in the group of people who had cancer, that SNP could be linked to increased risk for that cancer.

Most of the SNPs the cancer teams identified are specific to one of the three cancers, but 17 are shared risk factors for all three. The new SNPs, combined with 75 previously known markers, explain a proportion of inherited genetic risk for these cancers: 28 percent for breast, 4 percent for ovarian and 30 percent for prostate cancer. The research was published as a collection of 13 papers in April in Nature Genetics, Nature Communications, PLoS Genetics, The American Journal of Human Genetics, and Human Molecular Genetics (Scientific American is part of Nature Publishing Group).

Comparing genomes to uncover SNPs of interest is one way that researchers dig down to find the genetic basis of complex diseases. "We get little bits that we put together," says Stephen Chanock, chief of the Laboratory of Translation Genomics at the National Cancer Institute. Chanock was involved in several of the new studies. Complex diseases such as cancer spring from many gene variants that all contribute to the disease. These studies are helping researchers fill in the list of risky genetic markers. "What is emerging is the complicated genetic architecture of different diseases," he says.

Following the signs

Rowley's swapped chromosomes eventually led researchers to find a way to treat CML. Now patients can take a pill that jams a monkey wrench into a process vital to the cancer's development. The drug, called imatinib (first marketed as Gleevec in the U.S.), often grants patients a normal life expectancy with minimal side effects. Few cancer treatments have met this high bar, but researchers still comb the genome for cancer's fingerprints and clues to what might stop the disease.

Indeed, the COGS findings provide signposts for future research. For example, a handful of SNPs associated with prostate cancer risk fall within genes important for the binding of a cell to a surface. That surface could be another cell to facilitate communication or create a barrier through which pathogens cannot pass. Cell–cell adhesion is important for immune response and is also involved in tumor metastasis—tumor cells use cell adhesion to stick to a new location in the body. Understanding the mechanisms for cell–cell adhesion may offer insights for new treatments.

In a number of regions the SNPs are involved in more than one type of cancer cluster. "In some cases we are beginning to understand why that is," said Doug Easton, a professor at the University of Cambridge and the lead author of the main breast cancer paper at a press conference before the papers were published. One of the COGS papers honed in on a genetic region that helps control the length of telomeres, which are protective caps on the end of DNA strands. The so-called TERT locus harbors SNPs relevant to both breast and ovarian cancer risk, making it a prime candidate for further study.

The next step for the international cancer teams is an even larger study with a new chip called OncoChip, made by Signature Genomics. They plan to screen 600,000 SNPs of interest to see if they are involved five malignancies—ovarian, breast and prostate as well as colorectal and lung cancers. The larger numbers will give the researchers more statistical power to uncover less common gene variants. In addition researchers will map the already discovered variants to figure out which genes and biochemical pathways are involved. Studies of gene function are critical to characterize cancer biology, says Mathieu Lupien, a scientist at the Ontario Cancer Institute and assistant professor at the University of Toronto who was not involved in COGS. "Now we can move forward and understand why it is those genetic defects promote cancer," he says.

Weighing the risks

Genetic markers may lead to better treatments, but researchers also hope to catch cancer before it starts.

Clinicians already use cancer-risk calculators to group people into high- and low-risk categories based on lifestyle choices, environment and family history. The new SNPs could be additional indicators that make the stratification more accurate and efficient. High-risk groups could get targeted recommendations for avoiding risky behaviors or whether to get screened for a type of cancer.

Currently, cancer screening is saddled with a lot of false positives, which means people who do not have cancer are told they are positive. Such results lead to unnecessary and even dangerous procedures—not to mention the anxiety felt by those who believe they have a potentially life-threatening disease. For example, screening for prostate, lung, colorectal and ovarian cancers in 68,436 people over a period of three years led to a least one false positive for 60 percent of men and 49 percent of women. Another study found that follow-up procedures (such as a biopsy) after a false positive cost an average of $1,024 for women and $1,171 for men. The challenge is figuring out where to draw the line for high-risk, says Ros Eeles, a professor of oncogenetics at the Institute of Cancer Research in London and one of the principal investigators involved in the main prostate cancer paper. "We could do the test and give a risk profile, but we don't know what you should do when you have the information," she says. Studies that retroactively profile genetic risk markers in patients could reveal where the lines should fall and what interventions are most effective.

"We're not to the point of being able to predict an individual's risk," says Joe Gray, a professor at Oregon Health & Science University's Knight Cancer Institute and not involved in the COGS studies. A more thorough understanding of risk factors and better cancer screening could lead to a future where doctors can "prevent people from having cancer we don't know how to treat," he says.

More information about how different genetic variants contribute to risk of disease could help refine the definition of high-risk groups. A well-tested SNP profile could sort out individuals at the top of the spectrum, where the benefits of screening would outweigh the risks. Once the genetic risk is understood, public health professionals can employ the same communication strategies used to counsel people about heart disease risk. "We do [stratified screening] all the time with cardiovascular risk," says Hilary Burton, director of the PHG Foundation based in England. Right now the evidence on breast cancer screening is "finely balanced between benefits and harm," she says. The newly identified SNPs can help tip the balance for some carefully identified individuals.

The vision the researchers outline could be in the not-too-distant future. People in their 40s today might see safer, stratified risk screening for some cancers within their lifetimes, Cambridge’s Easton said in a press conference. Still, before all patients can receive the benefits of safe screening, researchers will need to address a gap common to current genome-based discoveries: The 200,000 people in the COGS pool are largely of European descent and live Australia, North America and Europe. Whereas the consortium did find some risk markers specific to people of Asian descent, other genetic groups such as African and indigenous populations in the Americas and Australia are underrepresented.

"We are still very much in the discovery mode," Chanock says. Decades after uncovering the genetic basis of cancer, that is a sobering statement.

Follow Scientific American on Twitter @SciAm and @SciamBlogs.

Visit ScientificAmerican.com for the latest in science, health and technology news.

© 2013 ScientificAmerican.com. All rights reserved.

Sorry you didn't like this comment. Please provide a reason below.

Are you sure?
Rating failed. Try again.
Request failed. Try again.
We will promote constructive and witty comments to the top, so everyone sees them!
Sorry, we can’t load comments right now. Try again.

    Recommended for You

    • Trump slapped with federal lawsuit in New York

      A group of American lawyers on Monday filed a federal lawsuit in New York against Donald Trump, accusing the US president of violating a constitutional ban on accepting payments from foreign governments. The Citizens for Responsibility and Ethics in Washington (CREW) is pursuing Trump over his vast business holdings, from which the billionaire has refused to divest fully, saying that as president he can have no conflict of interest. CREW says Trump's business properties abroad operate based partly on goodwill from foreign governments and regulators, but that under the US Constitution no federal official can receive a gift or "emolument" from a foreign government.

      AFP
    • Wawrinka wins grudge match at Australian Open as Venus shines

      Stan Wawrinka won a bad-tempered clash with Jo-Wilfried Tsonga to reach the Australian Open semi-finals as Venus Williams' late-career surge sent her soaring into the last four on Tuesday. Wawrinka and France's Tsonga, who have been at odds in the past, argued heatedly at the first-set changeover and there was no love lost as the Swiss charged to a 7-6 (7/2), 6-4, 6-3 win. It puts 2014 champion Wawrinka, 31, into his third Melbourne semi-final where he will play the ever-popular Roger Federer, his Swiss compatriot, or Mischa Zverev.

      AFP
    • Man convicted of 3 murders as teen kills himself in prison

      CAMP HILL, Pa. (AP) — A man who broke into a classmate's home in 2007 and stabbed the teenager and his parents to death has killed himself in prison, authorities said Monday.

      Associated Press
    • Minnesota Gov. Dayton, 69, collapses during speech

      ST. PAUL, Minn. (AP) — Gov. Mark Dayton collapsed while delivering his State of the State speech on Monday, striking his head on a lectern. The 69-year-old Democrat appeared to be conscious as he was helped into a back room several minutes later, and a top staffer said he walked out of the Capitol under his own power.

      Associated Press
    • What's in the Box? Social Media Goes Wild Over Tiffany's Gift Melania Trump Gave Michelle Obama

      It led to an awkward exchange after Michelle Obama was unsure what to do with the gift.

      Inside Edition
    • The Sig P320 is the U.S. Army's New Sidearm

      The new pistol replaces the 80s vintage M9 handgun.

      Popular Mechanics
    • People
    • Royals' Ventura killed in car crash in Dominican Republic

      KANSAS CITY, Mo. (AP) — Yordano Ventura quit school as a teenager so he could begin working a construction job to help his family make ends meet, laboring day after day in the hot sun of the Dominican Republic.

      Associated Press
    • Firebrand Iraq cleric warns US on Israel embassy move

      Moving the US embassy in Israel from Tel Aviv to Jerusalem would be a declaration of war on Islam, influential Iraqi cleric Moqtada al-Sadr said Tuesday. "Transferring the US embassy to Jerusalem would be a public and more-explicit-than-ever declaration of war against Islam," he said in a statement. In a break with previous administrations, new US President Donald Trump has pledged to recognise Jerusalem as Israel's capital and relocate the US embassy there from Tel Aviv.

      AFP
    • Chelsea Clinton shuts down trolls who targeted Barron Trump

      Former First Daughter Chelsea Clinton has spoken out in defence of Barron Trump, the US president's youngest son, after trolls targeted him with cruel memes online during the inauguration.  In a Facebook post Chelsea, who spent much of her teenage years in the spotlight while her dad Bill Clinton was president, said the 10-year-old "deserves the chance every child does-to be a kid".  But she also turned political: "Standing up for every kid also means opposing POTUS policies that hurt kids". Criticism of Barron's facial expressions and posture during the inauguration was widespread on social media, with people mocking him and calling him out for looking bored.  A Saturday Night Live writer even tweeted: "Barron will be this country's first homeschool shooter". The tweet was later deleted.  People on Facebook praised Chelsea for defending Barron while also expressing her political ideas:  BONUS: Donald Trump's inauguration address included a Bane quote ›

      Mashable
    • 12 bodies found in Mexican tourist town: officials

      A dozen bodies -- including seven that were headless and mutilated -- were discovered over the weekend in western Mexico's seaside resort of Manzanillo, apparent victims of the country's epidemic of drug violence, local officials said. It was a shocking turn of events for an area popular with American and other foreign tourists, which until now had largely been spared from the bloody drug wars wracking other parts of Mexico. Seven bodies were found early Saturday in an abandoned taxi on the road from Manzanillo to the town of Cihuatlan.

      AFP
    • Samsung: ‘A better, safer, and very innovative’ Galaxy Note 8 is coming

      Samsung completed its Galaxy Note 7 investigation and shared the results with the world on Monday. The company also unveiled a new 8-point quality assurance plan meant to prevent battery accidents from occurring on future Galaxy phones — and one of the phones that will benefit from the new safety policies is going to be the Galaxy Note 8. Yes, Samsung confirmed that it’s making “a better, safer and very innovative Note 8” just a few days ahead of its press conference on Monday. Samsung mobile boss DJ Koh spoke to CNET on Thursday about the Galaxy Note 7 fires. But Koh also let it slip that the Galaxy Note 7 won’t be the last phablet in the Note series. "I will bring back a better, safer and very innovative Note 8," Koh actually said, which a clear confirmation that a Galaxy Note 8 is indeed in the works. Samsung may have elaborated on the “safer” part during its press event on Monday, but it’s unclear at this time what “better” and “very innovative” mean. The Galaxy Note was the first big-screen smartphone that people flocked to, making Samsung the godfather of the phablet. The phone has plenty of fans, and Samsung says that Note fans are very devoted. In fact, 4% of the potentially faulty Galaxy Note 7 units that were sold are still in use out there — though most of them can’t even be used as phones anymore thanks to software limitations that have been put in place. "We found through the investigative process, we knew there are lots and lots of loyal Note customers," Koh said. Note fans are Samsung's most loyal base of clients across all of its products, the company said. According to Samsung’s Tim Baxter, president of the company's US division, more than 10,000 Note customers signed up to stay connected to Samsung for more updates. On top of that, there’s a large base of Galaxy Note 4 and Note 5 users who want an upgrade. "They made it clear, they want a Note," Baxter said. The Galaxy Note 8 likely won't launch until sometime this fall, but in the meantime, at least we all know for certain that the phone is coming.

      BGR News
    • Protesters take control of Mexican border crossing with US

      TIJUANA, Mexico (AP) — Protesters took control of vehicle lanes at one of the busiest crossings on the U.S. border Sunday to oppose Mexican gasoline price hikes, waving through motorists into Mexico after Mexican authorities abandoned their posts.

      Associated Press
    • 2018 BMW M4: Light Updates

      This year's evolution of the M4.

      Car and Driver
    • A Plea to Trump Fans: This Man is Dangerous

      The president is not just lying to you and me—now he’s lying to himself.

      GQ
    • Hugo Barra leaves Xiaomi, says China has ‘taken a huge toll on my life’

      Smartphone startup Xiaomi began life as a peculiar beast. From within the safety of China, the company did all it could to copy every last detail of Apple's devices and marketing strategy, knowing there was precious little Apple could do to stop it. When Apple's portfolio was exhausted, Xiaomi moved on to Samsung, copying a large portion of its device lineup as well. But then, the company realized that it could only go so far selling phones in China and a handful of other markets. As growth was on track to slow substantially, Xiaomi knew that it had to work its way into other top-tier markets around the world. And so Xiaomi Global was born. The Xiaomi subsidiary has hit a few rough patches over the course of the past three-plus years, but today may be its roughest to date. On Monday, Xiaomi Global VP Hugo Barra announced that he is leaving the company. In a post on Facebook, Barra confirmed that he is leaving the company and moving back to Silicon Valley. "When Lei Jun and Bin Lin came to me nearly four years ago with the opportunity to help turn a young rockstar startup into a global player, I embarked on what has been the greatest and most challenging adventure of my life," Barra wrote . "I moved to Beijing, 6,500 miles out of my comfort zone in Silicon Valley, to build from scratch a startup team within a bigger startup. This journey has been nothing short of spectacular in every way, and I can proudly say that Xiaomi Global is the first baby I helped bring into the world." Then, his post took a curious turn. "But what I've realized is that the last few years of living in such a singular environment have taken a huge toll on my life and started affecting my health," Barra said. "My friends, what I consider to be my home, and my life are back in Silicon Valley, which is also much closer to my family. Seeing how much I've left behind these past few years, it is clear to me that the time has come to return." It's unclear exactly what Barra means when he says that working at Xiaomi in Beijing has "taken a huge toll" on his life and affected his health, but he goes on to run down some of the things Xiaomi Global has accomplished since he joined the company. Most notably, the company has expanded sales into Russia, Mexico, Malaysia and more than 20 additional markets. Of note, Barra will still play a role at Xiaomi moving forward. Mi president and cofounder Bin Lin confirmed in a post on Facebook that Barra will be an advisor to the company following his departure. "When Hugo joined us 3.5 years ago, we started an amazing adventure to turn Xiaomi into a global player," Lin wrote . "We have come a long way since, and I couldn’t thank him enough for contributing so much to Xiaomi’s journey. As much as we would love to have Hugo stay with us in Beijing for a much longer time, we understand his personal challenges and wish him all the best in his future endeavors. I’m also looking forward to working closely with him in his new role as advisor to Xiaomi."

      BGR News
    • Philippine leader tames his words for Miss Universe hopefuls

      MANILA, Philippines (AP) — Philippine President Rodrigo Duterte delivered a speech without sex jokes and expletives Monday, telling a gathering of Miss Universe contestants that he was told to be careful with his language.

      Associated Press
    • Gambia's central bank accounts "intact", says president's spokesman

      By Lamin Jahateh BANJUL (Reuters) - Gambia's central bank deposits are "intact", a spokesman for President Adama Barrow said on Monday, a day after the new leader had said there was no money left in the state coffers. Barrow said on Sunday that it appeared his exiled predecessor, Yahya Jammeh, had looted state resources after his election defeat. A Barrow adviser later said Jammeh had withdrawn the equivalent of over $11.5 million before he flew out of the country as West African troops were poised to remove him.

      Reuters
    • Trump makes early move on restricting abortions around the world

      By Ellen Wulfhorst NEW YORK (Thomson Reuters Foundation) - U.S. President Donald Trump on Monday reinstated a global gag rule that bans U.S.-funded groups around the world from discussing abortion, a move that was widely expected but nonetheless dismayed women's rights advocates. The rule, which affects American non-governmental organizations working abroad, is one that incoming presidents have used to signal their positions on abortion rights. It was created under U.S. President Ronald Reagan in 1984.

      Reuters
    • Dwarf galaxies shed light on dark matter

      The first sighting of clustered dwarf galaxies bolsters a leading theory about how big galaxies such as our Milky Way are formed, and how dark matter binds them, researchers said Monday. Seven clusters of three-to-five galaxies are each 10 to 1,000 times smaller than the Milky Way. "We suspect these groups are gravitationally bound and thus will eventually merge to form one larger, intermediate-mass galaxy," said lead author Sabrina Stierwalt, an astrophysicist at the National Radio Astronomy Observatory in Charlotteville, Virginia.

      AFP